Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer

ClinicalTrials.gov ID: NCT02106546

Public ClinicalTrials.gov record NCT02106546. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 7:59 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Multicenter, Phase 3 Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Previously Untreated Advanced or Metastatic Squamous Non-Small Cell Lung Cancer (NSCLC)

Study identification

NCT ID
NCT02106546
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
970 participants

Conditions and interventions

Interventions

  • Carboplatin Drug
  • Veliparib Drug
  • Paclitaxel Drug
  • Placebo to veliparib Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 99 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 9, 2014
Primary completion
Jan 2, 2017
Completion
Nov 19, 2019
Last update posted
Nov 16, 2020

2014 – 2019

United States locations

U.S. sites
38
U.S. states
22
U.S. cities
33
Facility City State ZIP Site status
Northeast Arkansas Clinical Ch /ID# 128071 Jonesboro Arkansas 72401
LA Hem-Oncology Med Group /ID# 129178 Los Angeles California 90017
VA Eastern Colorado Healthcare System /ID# 128065 Aurora Colorado 80045
Holy Cross Hospital /ID# 128074 Fort Lauderdale Florida 33308
University of Florida - Archer /ID# 126476 Gainesville Florida 32610
Cancer Specialists of North Florida - Southpoint /ID# 127815 Jacksonville Florida 32256
Winship Cancer Institute of Emory University /ID# 124061 Atlanta Georgia 30322-1013
St. Luke's Mountain States Tumor Institute - Boise /ID# 124059 Boise Idaho 83712
Illinois Cancer Specialists /ID# 127468 Arlington Heights Illinois 60005
NorthShore University HealthSystem - Evanston Hospital /ID# 128585 Evanston Illinois 60201
Ingalls Memorial Hosp /ID# 128360 Harvey Illinois 60426
Midwestern Regional CTC /ID# 126124 Zion Illinois 60099
Goshen Center for Cancer Care /ID# 123875 Goshen Indiana 46526
Franciscan St. Francis Health /ID# 126678 Indianapolis Indiana 46237
Appalachian Regional Healthcare, Inc (ARH) /ID# 128061 Hazard Kentucky 41701
Henry Ford Health System /ID# 126500 Detroit Michigan 48202
Sparrow Regional Cancer Center, Sparrow Health System /ID# 127156 Lansing Michigan 48912
Minnesota Oncology Hematology, PA /ID# 127473 Minneapolis Minnesota 55404
Nebraska Hematology Oncology /ID# 127699 Lincoln Nebraska 68506
SE Nebraska Hema/Oncology Consultants P.C.d/b/a Southeast Nebraska Cancer Center /ID# 126477 Lincoln Nebraska 68510
Comprehensive Cancer Ctrs Neva /ID# 127491 Las Vegas Nevada 89169
Dartmouth-Hitchcock Medical Center /ID# 128075 Lebanon New Hampshire 03756
Hackensack Univ Med Ctr /ID# 124057 Hackensack New Jersey 07601
Gabrail Cancer Center Research /ID# 127415 Canton Ohio 44718
Penn State University and Milton S. Hershey Medical Center /ID# 126676 Hershey Pennsylvania 17033
The Jones Clinic, PC /ID# 124062 Germantown Tennessee 38138
Texas Oncology - Austin Midtown /ID# 127477 Austin Texas 78705
Texas Oncology - South Austin /ID# 127476 Austin Texas 78745
Parkland Health and Hosp Syste /ID# 128518 Dallas Texas 75235
Texas Oncology- Baylor Charles A. Sammons Cancer Center /ID# 128385 Dallas Texas 75246-2003
UT Southwestern Medical Center /ID# 127876 Dallas Texas 75390-7208
University of Texas MD Anderson Cancer Center /ID# 127946 Houston Texas 77030
Texas Oncology - Paris /ID# 127484 Paris Texas 75460
Texas Oncology - Waco /ID# 127459 Waco Texas 76712
University of Vermont Medical Center /ID# 128064 Burlington Vermont 05401-1473
Virginia Oncology Associates /ID# 127458 Norfolk Virginia 23502
Northwest Cancer Specialists, P.C. /ID# 127486 Vancouver Washington 98684
Northwest Cancer Specialists, P.C. /ID# 127488 Vancouver Washington 98684

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 187 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02106546, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 16, 2020 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02106546 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →